Elanco Animal Health ELAN
NYSE ELAN
$26.41 -0.37 (-1.38%)
At close: Nov 16, 2026 · 4:00 PM EST

Elanco Animal Health (ELAN) Non Operating Interest Expenses (2018 - 2026)

Updated

Elanco Animal Health's Non Operating Interest Expenses came in at $59 million for Q3 2026, up 13.5% from $52 million a year earlier and unchanged from the prior quarter.

Analysis

Elanco Animal Health (ELAN) Non Operating Interest Expenses (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Elanco Animal Health reported Non Operating Interest Expenses of $255 million, up 37.1% year-over-year; for FY2025, it came in at $220 million, down 6.4% from FY2024.

  • Non Operating Interest Expenses carries a five-year compound annual growth rate of 8.0% (FY2020 to FY2025).
  • Going back by year, Non Operating Interest Expenses was $235 million in FY2024 (-15.2%), $277 million in FY2023 (+14.9%), $241 million in FY2022 (+2.1%) and $236 million in FY2021 (+57.3%).
  • The five-year range for quarterly Non Operating Interest Expenses is $40 million (Q1 2025) to $80 million (Q4 2025).
  • Year-over-year, Non Operating Interest Expenses has increased for four consecutive quarters, with growth averaging 5.7% over the last eight quarters.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q4 2025 (growth of 73.9%), and the weakest in Q1 2025 (a decline of 39.4%).
  • Business Quant data shows ELAN's Non Operating Interest Expenses at $59 million (Q2 2026), $57 million (Q1 2026) and $80 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 217.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -477.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 269.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Elanco Animal Health 13.25 Bn 11.29 Bn 720.00 Mn 59.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 59.00 Mn
Jun 30, 2026 59.00 Mn
Mar 31, 2026 57.00 Mn
Dec 31, 2025 80.00 Mn
Sep 30, 2025 52.00 Mn
Jun 30, 2025 48.00 Mn
Mar 31, 2025 40.00 Mn
Dec 31, 2024 46.00 Mn
Sep 30, 2024 58.00 Mn
Jun 30, 2024 65.00 Mn
Mar 31, 2024 66.00 Mn
Dec 31, 2023 67.00 Mn
Sep 30, 2023 72.00 Mn
Jun 30, 2023 74.00 Mn
Mar 31, 2023 64.00 Mn
Dec 31, 2022 62.00 Mn
Sep 30, 2022 60.00 Mn
Jun 30, 2022 67.00 Mn
Mar 31, 2022 52.00 Mn
Dec 31, 2021 55.00 Mn
API Access

Elanco Animal Health Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ELAN&period=max&api_key=YOUR_API_KEY